Kintegral Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.46M | Hold |
15,885
| – | – | 0.12% | 150 |
|
|
2026
Q1 | $1.35M | Sell |
15,885
-704
| -4% | -$62.7K | 0.13% | 152 |
|
|
2025
Q4 | $1.31M | Sell |
16,589
-454
| -3% | -$35.6K | 0.11% | 156 |
|
|
2025
Q3 | $1.36M | Sell |
17,043
-76
| -0.4% | -$6.48K | 0.12% | 156 |
|
|
2025
Q2 | $1.56M | Sell |
17,119
-26
| -0.2% | -$2.37K | 0.14% | 146 |
|
|
2025
Q1 | $1.61M | Sell |
17,145
-58
| -0.3% | -$5.19K | 0.16% | 137 |
|
|
2024
Q4 | $1.56M | Sell |
17,203
-802
| -4% | -$76.5K | 0.15% | 144 |
|
|
2024
Q3 | $1.87M | Sell |
18,005
-236
| -1% | -$24.1K | 0.17% | 133 |
|
|
2024
Q2 | $1.77M | Sell |
18,241
-53,122
| -74% | -$4.9M | 0.17% | 131 |
|
|
2024
Q1 | $6.43M | Sell |
71,363
-222
| -0.3% | -$18.8K | 0.64% | 37 |
|
|
2023
Q4 | $5.71M | Sell |
71,585
-456
| -0.6% | -$34.3K | 0.63% | 40 |
|
|
2023
Q3 | $5.12M | Sell |
72,041
-43
| -0.1% | -$3.21K | 0.63% | 39 |
|
|
2023
Q2 | $5.55M | Hold |
72,084
| – | – | 0.66% | 39 |
|
|
2023
Q1 | $5.42M | Sell |
72,084
-3,873
| -5% | -$288K | 0.7% | 39 |
|
|
2022
Q4 | $5.98M | Buy |
75,957
+52,166
| +219% | +$3.91M | 0.79% | 32 |
|
|
2022
Q3 | $1.67M | Hold |
23,791
| – | – | 0.23% | 107 |
|
|
2022
Q2 | $1.91M | Buy |
23,791
+504
| +2% | +$39.4K | 0.25% | 98 |
|
|
2022
Q1 | $1.77M | Buy |
23,287
+521
| +2% | +$41.3K | 0.19% | 113 |
|
|
2021
Q4 | $1.94M | Hold |
22,766
| – | – | 0.2% | 114 |
|
|
2021
Q3 | $1.72M | Hold |
22,766
| – | – | 0.2% | 117 |
|
|
2021
Q2 | $1.85M | Hold |
22,766
| – | – | 0.22% | 111 |
|
|
2021
Q1 | $1.79M | Hold |
22,766
| – | – | 0.23% | 107 |
|
|
2020
Q4 | $1.95M | Hold |
22,766
| – | – | 0.26% | 96 |
|
|
2020
Q3 | $1.76M | Sell |
22,766
-733
| -3% | -$55.9K | 0.27% | 92 |
|
|
2020
Q2 | $1.72M | Hold |
23,499
| – | – | 0.28% | 90 |
|
|
2020
Q1 | $1.56M | Buy |
23,499
+2,629
| +13% | +$185K | 0.3% | 86 |
|
|
2019
Q4 | $1.44M | Hold |
20,870
| – | – | 0.26% | 99 |
|
|
2019
Q3 | $1.53M | Hold |
20,870
| – | – | 0.31% | 93 |
|
|
2019
Q2 | $1.5M | Hold |
20,870
| – | – | 0.3% | 94 |
|
|
2019
Q1 | $1.43M | Buy |
20,870
+10,930
| +110% | +$706K | 0.3% | 95 |
|
|
2018
Q4 | $592K | Buy |
+9,940
| New | +$622K | 0.18% | 115 |
|
Other funds holding CL
Kintegral Advisory's CL Position: Q2 2026 in Review
Kintegral Advisory held its Colgate-Palmolive (CL) position steady in Q2 2026 at 15,885 shares worth $1.46M. The position accounts for 0.12% of the portfolio, ranked #150.
Kintegral Advisory first reported a position in CL in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.43M in Q1 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Kintegral Advisory held 15,885 shares of Colgate-Palmolive worth $1.46M as of Q2 2026.
- Kintegral Advisory left its Colgate-Palmolive share count unchanged in Q2 2026.
- Colgate-Palmolive made up 0.12% of Kintegral Advisory's portfolio in Q2 2026, its #150 holding.
- Kintegral Advisory first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 31 quarters since.
- Kintegral Advisory's Colgate-Palmolive position peaked at $6.43M in Q1 2024.
- 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.